Stock SONN SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Market Closed - Nasdaq
Other stock markets
 20:59:31 28/06/2024 BST 		5-day change 1st Jan Change
0.9375 USD -1.15% Intraday chart for Sonnet BioTherapeutics Holdings, Inc. -4.34% -46.12%
06-20 Top Midday Decliners MT
06-13 Sonnet BioTherapeutics Holdings, Inc. Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain CI

Chart calendar Sonnet BioTherapeutics Holdings, Inc.

9bfacf6d0e3904.LbB62mhIvBsS8qWLuXrhaqryF4x9a_OVzQtj53eE5Oc.RMgbtQU7j1F2m8PezTiuXOTfJNQONJzf-T8JhAHb3KZs8x7qBiXMVGrG6A~e30b719f21938e16680c72efdade46c8

Upcoming events on Sonnet BioTherapeutics Holdings, Inc.

11/08/2024 Q3 2024 Earnings Release (Projected)
11/12/2024 Q4 2024 Earnings Release (Projected)
17/02/2025 Q1 2025 Earnings Release (Projected)
19/05/2025 Q2 2025 Earnings Release (Projected)

Past events on Sonnet BioTherapeutics Holdings, Inc.

14/05/2024 EF Hutton Investor Conference
14/05/2024 21:15 Q2 2024 Earnings Release
10/04/2024 14:00 American Association for Cancer Research Meeting - Abstract Number: 7181
14/02/2024 12:30 Q1 2024 Earnings Release
14/12/2023 21:15 Q4 2023 Earnings Release
02/11/2023 17:30 Connective Tissue Oncology Society Meeting - Abstract Number: 1566754
31/08/2023 Reverse Split: 1 of 22
31/08/2023 14:00 Annual General Meeting
14/08/2023 13:00 Q3 2023 Earnings Release
07/08/2023 17:00 BTIG Virtual Biotechnology Conference
29/06/2023 19:40 Cytokine-Based Drug Development Summit - Richard Kenney
27/06/2023 18:00 Cytokine-Based Drug Development Summit - John Cini
10/05/2023 12:30 Q2 2023 Earnings Release
18/04/2023 22:00 American Association for Cancer Research Meeting
18/04/2023 18:30 American Association for Cancer Research Meeting - Abstract No: CT245
13/02/2023 13:00 Q1 2023 Earnings Release
02/11/2022 12:30 Business Update Call
18/09/2022 Reverse Split: 1 of 14
15/08/2022 21:05 Q3 2022 Earnings Release
23/06/2022 14:00 Annual General Meeting

Annual results

Fiscal PeriodSeptember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,48
0,00
- 		0,35
0,40
-12.52%		0,15
0,15
1.47%
0,04

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-25,1
-24,7
-1.75%		0,00
0,00
- 		-18,8
-16,7
-12.42%
-13,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-25,0
-24,5
-2.05%		0,00
0,00
- 		-18,8
-16,7
-12.66%
-13,0

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-25,0
-24,5
-2.05%		0,00
0,00
- 		-18,8
-16,7
-12.78%
-13,0

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-314
-320
1.92%		-150
-147
-2.4%		-18,1
-28,1
35.51%
-2,15

Announcement Date17/12/2017/12/2115/12/2214/12/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,10
0,05
90.64%		0,06
0,05
24.14%		0,06
0,10
-37.25%		0,04
0,10
-62.74%		0,04
0,00
- 		0,04
0,00
- 		0,04
0,02
99.57%		0,02
0,01
55.25%		0,00
0,01
-
0,02


0,02

EBIT
Million USD		Released
Forecast
Spread 		-8,21
-10,0
17.9%		-7,87
-9,00
12.59%











-3,60
-4,38
17.79%		-1,28
-3,64
64.84%		-3,87
-1,60
-141.11%
-3,88


-3,98

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,21
-10,0
17.92%		-7,88
-9,00
12.48%











-3,68
-4,38
16.04%		-1,17
-3,64
67.87%		0,37
0,55
-33.92%
-3,88


-3,98

Net income
Million USD		Released
Forecast
Spread 		-8,21
-10,0
17.92%		-7,88
-9,00
12.48%











-3,68
-4,38
16.04%		-1,17
-3,64
67.87%		0,37
0,55
-33.92%
-3,88


-3,98

EPS
USD		Released
Forecast
Spread 		-43,1
-40,0
-7.69%		-40,0
-43,1
7.14%		-37,2
-33,2
-11.92%		-17,6
-24,2
27.27%		-7,48
-10,9
31.31%		-2,86
-6,38
55.17%		-17,3
-4,09
-322.15%		-0,31
-0,86
63.95%		0,07
-0,28
125.3%
-0,77


-0,64

Announcement Date10/05/2215/08/2215/12/2213/02/2310/05/2314/08/2314/12/2314/02/2414/05/24--

Upcoming sector events for Sonnet BioTherapeutics Holdings, Inc.

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 11:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Sonnet BioTherapeutics Holdings, Inc.

21/06/2024 16:28 DEVA HOLDING: Q1 2024 Earnings Release
13/06/2024 22:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 06:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 11:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 10:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 10:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SONN Stock
  4. Calendar Sonnet BioTherapeutics Holdings, Inc.